益方生物 (688382.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(益方生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 4,283,084.626,267,169.528,606,045.1058,357,055.5347,169,811.32--
 营业收入(元) 4,283,084.626,267,169.528,606,045.1058,357,055.5347,169,811.32--
二、营业总成本(元) 102,632,668.24133,651,596.7391,335,787.5297,131,079.95122,336,679.39130,584,938.28119,810,412.20
 营业成本(元) 713,775.752,272,660.504,044,612.85----
 研发费用(元) 86,765,416.51124,158,473.0184,752,226.6093,901,885.88111,801,241.62127,039,805.17110,164,964.97
 营业税金及附加(元) 9,778.9531,788.0729,340.6225,841.2163,760.3416,909.4118,427.44
 管理费用(元) 18,887,517.2313,652,585.7010,644,755.9222,374,148.2313,137,613.6312,342,363.9612,997,727.72
 财务费用(元) -3,743,820.20-6,463,910.55-8,135,148.47-19,170,795.37-2,665,936.20-8,814,140.26-3,370,707.93
  其中:利息费用(元) ----631,814.91273,705.77252,772.02288,226.64
  其中:利息收入(元) -5,512,827.40-6,141,132.74-8,058,138.5846,342,275.13-4,097,169.82-2,316,659.75-6,034,094.66
 信用减值损失(元) -208,581.06-4,092,892.11-447,924.66-6,939,362.94-5,512.05-2,401,025.11-1,358.47
三、其他经营收益
 加:公允价值变动收益(元) 570,000.00----3,100,000.001,800,000.00
 其他收益(元) 6,900,000.00--3,000,000.00-6,925.35141,420.08
四、营业利润(元) -91,088,164.68-131,040,677.96-83,177,667.08-42,713,387.36-73,512,498.62-49,879,038.04-117,870,350.59
五、利润总额(元) -91,088,164.68-131,040,677.96-83,177,667.08-42,713,387.36-73,512,498.62-49,879,038.04-117,870,350.59
六、净利润(元) -91,088,164.68-131,040,677.96-83,177,667.08-42,713,387.36-73,512,498.62-49,879,038.04-117,870,350.59
(一)按经营持续性分类
  持续经营净利润(元) -91,088,164.68-131,040,677.96-83,177,667.08-42,713,387.36-73,512,498.62-49,879,038.04-117,870,350.59
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -91,088,164.68-131,040,677.96-83,177,667.08-42,713,387.36-73,512,498.62-49,879,038.04-117,870,350.59
 扣除非经常性损益后的净利润(元) -98,558,164.68-131,477,319.32-83,177,667.08-45,713,387.36-75,172,380.12-52,985,963.39-119,811,770.67
七、每股收益
 一、基本每股收益(元) -0.16-0.23-0.14-0.07-0.13-0.09-0.20
 二、稀释每股收益(元) -0.16-0.23-0.14-0.07-0.13-0.09-0.20
八、其他综合收益(元) -645,334.93-390,983.80-593,516.15254,447.09-489,505.81-521,934.36419,135.55
 归属于母公司股东的其他综合收益(元) -645,334.93-390,983.80-593,516.15254,447.09-489,505.81-521,934.36419,135.55
九、综合收益总额(元) -91,733,499.61-131,431,661.76-83,771,183.23-42,458,940.27-74,002,004.43-50,400,972.40-117,451,215.04
 归属于母公司所有者的综合收益总额(元) -91,733,499.61-131,431,661.76-83,771,183.23-42,458,940.27-74,002,004.43-50,400,972.40-117,451,215.04
公告日期 2024-10-302024-08-232024-04-302024-04-262023-10-282023-08-222023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院